Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shoutai Pill is a classic Traditional Chinese Medicine (TCM) formula primarily used in reproductive health. It is traditionally indicated for kidney deficiency leading to conditions such as threatened miscarriage, habitual abortion, and infertility. In modern clinical research, it is being evaluated for its efficacy in treating Diminished Ovarian Reserve (DOR) and improving outcomes in In Vitro Fertilization-Embryo Transfer (IVF-ET). The formula typically consists of four main herbs: *Cuscuta chinensis* (Tu Si Zi), *Taxillus chinensis* (Sang Ji Sheng), *Dipsacus asper* (Xu Duan), and *Asinus asini* (E Jiao). Its mechanism is thought to involve the regulation of the hypothalamic-pituitary-ovarian (HPO) axis, improvement of ovarian blood flow, and modulation of follicular fluid metabolomics to enhance oocyte quality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shoutai Pill.